Polar Capital's Douglas 'optimistic' on defensive healthcare

Eye on large-cap pharma and biotech

Jenna Brown
clock • 3 min read

Defensive areas within healthcare provide nuggets of optimism, with large-cap pharmaceuticals and large-cap biotechnology particularly favoured, Polar Capital has said.

James Douglas, fund manager within the global healthcare team, said large-cap pharma and biotech have collective strong balance sheets, good cashflow conversation and secure dividend yields, where applicable. He said areas where "sentiment collapsed" during March included medical devices and healthcare facilities due to the delays in non-urgent procedures at hospitals. Small and mid-caps were also hit hard due to perceived higher risk. Douglas said: "On a one and three-year view, areas hit hardest with the worst sentiment offer compelling returns. "Assuming some kind of resumption ...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Funds

Passive asset managers pick up steam in fund selector rankings

Passive asset managers pick up steam in fund selector rankings

Broadridge Fund Brand 50 Report

clock 26 March 2024 • 2 min read
Robeco expands emerging markets equity range with ex-China strategy

Robeco expands emerging markets equity range with ex-China strategy

More ‘balanced’ exposure to EM

Valeria Martinez
clock 26 March 2024 • 2 min read
Morningstar downgrades Fundsmith Equity due to 'wrongly timed' exits

Morningstar downgrades Fundsmith Equity due to 'wrongly timed' exits

Adobe, Amazon, Estee Lauder and PayPal

clock 25 March 2024 • 1 min read
Trustpilot